Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-03

Clinical Trial Update: Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia [Phase 4]

View source ↗

Summary

This Phase 4 trial update discusses a shortened 5-day antibiotic course for treating community-acquired pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Thomas Benfield | Conditions: Community-acquired Pneumonia | Phase 4 | Status: COMPLETED